Therapy of estrogen-associated disorders
AssigneeNovogen Research Pty. Ltd.
InventorsGraham Edmund Kelly, Alan James Husband
Life of this patent
Estimating the term…
Abstract
A method for the treatment, prophylaxis, amelioration or prevention of disorders associated with abnormally high activity of steroidal estrogens, which includes administering to a human subject a composition comprising an isoflavone-containing extract of clover or chick peas, said extract comprising primarily biochanin, or a ratio of biochanin to one or more of the isoflavones from the group formononetin, daidzein and genistein in the range of from about 2:1 to about 5:1, optionally in association with one or more pharmaceutically acceptable carriers, excipients, auxiliaries and/or diluents is described. Also described are compositions and uses comprising the isoflavone containing extracts.
Claims9
A method of treatment or amelioration of pre-menopausal, benign disorders associated with an abnormally high activity of steroidal estrogen, comprising administering to a human subject a composition comprising at least about 65% biochanin and at least one other isoflavone selected from formononetin, daidzein and genistein, at a ratio front about 2:1 to about 5:1.
Dependencies are inferred from the claim text.